Mycobutin

— THERAPEUTIC CATEGORIES —
  • Bacterial infections

Mycobutin Generic Name & Formulations

General Description

Rifabutin 150mg; hard-gel caps.

Pharmacological Class

Rifamycin.

How Supplied

Caps—100

Manufacturer

Generic Availability

YES

Mycobutin Indications

Indications

Prevention of disseminated Mycobacterium avium complex (MAC) disease in advanced HIV infection.

Mycobutin Dosage and Administration

Adult

≥18yrs: 300mg once daily. If inclined to GI upset, may give 150mg twice daily with food. Severe renal impairment (CrCl <30mL/min), concomitant amprenavir, indinavir, or nelfinavir: reduce rifabutin dose by 50%. Concomitant ritonavir, fosamprenavir/ritonavir, lopinavir/ritonavir, saquinavir/ritonavir, tipranavir/ritonavir: reduce rifabutin dose by 75% (to max 150mg every other day or 3 times per week).

Children

<18yrs: not established.

Mycobutin Contraindications

Contraindications

Concomitant delavirdine, voriconazole.

Mycobutin Boxed Warnings

Not Applicable

Mycobutin Warnings/Precautions

Warnings/Precautions

Active tuberculosis: do not administer. Evaluate and test for tuberculosis before and during therapy; treat with combination antituberculosis regimen if active disease occurs. Suspend therapy if uveitis is suspected. Monitor for severe cutaneous adverse reactions (eg, SJS, TEN, DRESS, AGEP). Do hematologic tests periodically. May stain body secretions and contact lenses. Moderate to severe hepatic impairment. Elderly. Pregnancy. Nursing mothers: not recommended.

Mycobutin Pharmacokinetics

See Literature

Mycobutin Interactions

Interactions

See Contraindications. Concomitant bictegravir, doravirine, rilpivirine: not recommended. Antagonizes dapsone, sulfamethoxazole-trimethoprim, zidovudine, oral contraceptives (use additional or alternative contraception methods) or drugs that are metabolized by CYP3A enzymes (eg, itraconazole, clarithromycin, indinavir, saquinavir/ritonavir, posaconazole). Potentiated by CYP3A inhibitors (eg, amprenavir, fluconazole, clarithromycin, indinavir, lopinavir/ritonavir, nelfinavir, posaconazole, saquinavir/ritonavir, tipranavir/ritonavir).

Mycobutin Adverse Reactions

Adverse Reactions

Discolored urine, GI upset, abdominal pain, dyspepsia, fever, myalgia, rash, taste perversion, neutropenia, thrombocytopenia, leukopenia; rare: myositis, uveitis.

Mycobutin Clinical Trials

See Literature

Mycobutin Note

Not Applicable

Mycobutin Patient Counseling

See Literature